MilliGraft at Arab Health 2022: mesenchymal stem cells to be protagonists of medical innovation

Dual Trend Srl is proud to announce its presence at Arab Health 2022, an event of global importance in the medicine field. The company will present MilliGraft ®, the patented, innovative and minimally invasive method that allows to select mesenchymal stem cells (MSCa) from adipose tissue

Turin | 17 January 2022

The company was chosen by Piedmont Region, which counted it among its medical excellencies. In fact, MilliGraft® will be present in the area dedicated to Piedmont, in the Italian Pavilion – Booth Z2 K19 (ZA’ ABEEL 2 HALL).

MilliGraft ® allows regenerative medicine and plastic / reconstructive medicine to count on a faster and more effective tissue regeneration process, thanks to the properties of MSCa cells. All without the risk of rejection.

The method, which is patented by Dual Trend, it is also applied in aesthetic medicine, since there are endless treatments that can be carried out thanks to cell regeneration: from facial rejuvenation with lifting effect, to filling with botox effect.

MilliGraft ® is also multidisciplinary, in fact it also finds application in the fields of general medicine, orthopedics, gynecology, trichology and veterinary medicine.
MilliGraft ® method is enclosed in a sterile disposable procedural kit, which contains everything necessary for the collection, processing and infusion of the suspension obtained through the minimally invasive procedure, which allows to find up to 1.300.000 live cells in 2 ml of suspension.

The procedural kit is available at an affordable price in order to allow Medicine to apply it on a large scale. Always looking for new international collaborations, Dual Trend will welcome visitors to Arab Health 2022 by showing MilliGraft ® and by providing all the detailed information on the most innovative method that allows to take advantage of mesenchymal stem cells.

Dual Trend Srl - -